Document is current
Any future updates will be listed below
-
Authors
Anbari, Samira https://orcid.org/0000-0003-4892-6446
Wang, Hanwen https://orcid.org/0000-0001-5480-431X
Arulraj, Theinmozhi https://orcid.org/0000-0002-7258-7512
Nickaeen, Masoud
Pilvankar, Minu
Wang, Jun https://orcid.org/0000-0002-0538-5910
Hansel, Steven
Popel, Aleksander S. https://orcid.org/0000-0002-6706-9235
-
Funding
Funding for this research was provided by:
Boehringer Ingelheim
U.S. Department of Health & Human Services | National Institutes of Health (R01CA138264 (ASP))
- License Information
-
More Information
Article History
Received: 19 November 2023
Accepted: 2 September 2024
First Online: 30 September 2024
Competing interests
: M.P., M.N., J.W., and S.H. are employees of Boehringer Ingelheim Pharmaceuticals, Inc. A.S.P. is a consultant to J&J/Janssen, Incyte, and AsclepiX Therapeutics. All other authors declare no competing interests.
